![Stephen M. Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen M. Chang
Technik-/Wissenschafts-/F&E-Leiter bei One Med Research Institute
Aktive Positionen von Stephen M. Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
One Med Research Institute | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Stephen M. Chang
Ehemalige bekannte Positionen von Stephen M. Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HISTOGEN INC. | Direktor/Vorstandsmitglied | 26.05.2020 | 24.03.2021 |
Independent Dir/Board Member | 26.05.2020 | 24.03.2021 | |
MultiCell Immunotherapeutics, Inc. | Präsident | 01.09.2005 | 21.12.2007 |
Canji, Inc.
![]() Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2004 |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2004 |
Stemgent, Inc. /New/
![]() Stemgent, Inc. /New/ BiotechnologyHealth Technology Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01.01.2008 | - |
New York Stem Cell Foundation, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 30.03.2011 | - |
Corporate Officer/Principal | 01.01.2010 | - | |
Histogen, Inc. /Old/
![]() Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 28.01.2019 | - |
Vorsitzender | 01.01.2007 | 28.01.2019 | |
Corporate Officer/Principal | 01.01.2007 | - | |
Asterand Biosciences, Inc.
![]() Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Technik-/Wissenschafts-/F&E-Leiter | 30.03.2011 | - |
Gründer | 01.01.2006 | - | |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Stephen M. Chang
University of California, Irvine | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 13 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 6 |
Health Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MULTICELL TECHNOLOGIES, INC. | Health Technology |
HISTOGEN INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Asterand Biosciences, Inc.
![]() Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Health Technology |
Canji, Inc.
![]() Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Schering-Plough Research Institute
![]() Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
New York Stem Cell Foundation, Inc. | Miscellaneous |
Histogen, Inc. /Old/
![]() Histogen, Inc. /Old/ Medical/Nursing ServicesHealth Services Histogen, Inc. is a regenerative medicine company. It focuses on developing patented technologies that replace and regenerates tissues in the body. The firm's applications include hair stimulating complex, matrix regeneration, and skin care. The company was founded in 2007 and is headquartered in San Diego, CA. | Health Services |
MultiCell Immunotherapeutics, Inc. | |
Stemgent, Inc. /New/
![]() Stemgent, Inc. /New/ BiotechnologyHealth Technology Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA. | Health Technology |
One Med Research Institute |
- Börse
- Insiders
- Stephen M. Chang
- Erfahrung